Administration of Zostavax® (zoster vaccine) in individuals who are immunocompromised is contraindicated due to the risk of causing disseminated disease. Prior to immunisation, and in conjunction with the pre-immunisation checklist, the Zostavax® GP Decision Aid should be completed to ensure patient safety. For further information on Zostavax®, please refer to the updated links below:
About MVEC
The Melbourne Vaccine Education Centre (MVEC) is an educational website, developed with the aim of providing up-to-date immunisation information for both healthcare professionals and members of the public. We are based at Murdoch Children’s Research Institute (MCRI), a research organisation, and are affiliated with SAEFVIC (Surveillance of Adverse Events Following Vaccination in the Community), the Victorian Vaccine Safety Service.